Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb 11:35:106863.
doi: 10.1016/j.dib.2021.106863. eCollection 2021 Apr.

Differential gene expression data from the human central nervous system across Alzheimer's disease, Lewy body diseases, and the amyotrophic lateral sclerosis and frontotemporal dementia spectrum

Affiliations

Differential gene expression data from the human central nervous system across Alzheimer's disease, Lewy body diseases, and the amyotrophic lateral sclerosis and frontotemporal dementia spectrum

Ayush Noori et al. Data Brief. .

Abstract

In Noori et al. [1], we hypothesized that there is a shared gene expression signature underlying neurodegenerative proteinopathies including Alzheimer's disease (AD), Lewy body diseases (LBD), and the amyotrophic lateral sclerosis and frontotemporal dementia (ALS-FTD) spectrum. To test this hypothesis, we performed a systematic review and meta-analysis of 60 human central nervous system transcriptomic datasets in the public Gene Expression Omnibus and ArrayExpress repositories, comprising a total of 2,600 AD, LBD, and ALS-FTD patients and age-matched controls which passed our stringent quality control pipeline. Here, we provide the results of differential expression analyses with data quality reports for each of these 60 datasets. This atlas of differential expression across AD, LBD, and ALS-FTD may guide future work to elucidate the pathophysiological drivers of these individual diseases as well as the common substrate of neurodegeneration.

Keywords: Alzheimer's disease; Amyotrophic lateral sclerosis; Differential expression; Frontotemporal dementia; Lewy body diseases; Meta-analysis; Neurodegeneration; Transcriptomics.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interests.

References

    1. Noori A., Mezlini A.M., Hyman B.T., Serrano-Pozo A., Das S. Systematic review and meta-analysis of human transcriptomics reveals neuroinflammation, deficient energy metabolism, and proteostasis failure across neurodegeneration. Neurobiol. Dis. 2021;149 doi: 10.1016/j.nbd.2020.105225. - DOI - PMC - PubMed
    1. Kauffmann A., Huber W. Microarray data quality control improves the detection of differentially expressed genes. Genomics. 2010;95:138–142. doi: 10.1016/j.ygeno.2010.01.003. - DOI - PubMed
    1. Kauffmann A., Gentleman R., Huber W. arrayQualityMetrics - a Bioconductor package for quality assessment of microarray data. Bioinformatics. 2009;25:415–416. doi: 10.1093/bioinformatics/btn647. - DOI - PMC - PubMed
    1. Liberati A., Altman D.G., Tetzlaff J., Mulrow C., Gøtzsche P.C., Ioannidis J.P.A., Clarke M., Devereaux P.J., Kleijnen J., Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. The BMJ. 2009;339 doi: 10.1093/10.1136/bmj.b2700. - DOI - PMC - PubMed
    1. Irizarry R.A., Hobbs B., Collin F., Beazer-Barclay Y.D., Antonellis K.J., Scherf U., Speed T.P. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostat. Oxf. Engl. 2003;4:249–264. doi: 10.1093/biostatistics/4.2.249. - DOI - PubMed

LinkOut - more resources